Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 16Hyperandrogenism 6Endometrial Neoplasms 4Endometrial Hyperplasia 2Breast Neoplasms 2Uterine Cervical Dysplasia 1Sleep Apnea, Obstructive 1Sleep Apnea Syndromes 1Progesterone Resistance 1Osteoporosis 1Obesity 1Infertility, Female 1Gliosarcoma 1Glioblastoma 1Coronary Disease 1Cardiovascular Diseases 1Brain Neoplasms 1Anovulation 1Abortion, Spontaneous 1

Interventions

Clomiphene 10Metformin 9Letrozole 3Medroxyprogesterone Acetate 2salicylsalicylic acid 1maltodextrin 1Vitamin D 1Ultrasonography 1Tamoxifen 1Sodium Salicylate 1Raloxifene Hydrochloride 1Progestins 1Progesterone 1Nimodipine 1Inulin 1Inositol 1Hematologic Tests 1Glycoprotein Hormones, alpha Subunit 1Folic Acid 1Flutamide 1Chorionic Gonadotropin 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Anovulation × Progesterone × Clear all
NCT03088046 2017-03-23

Circulating Androgen Levels Are Not Affected by the Administration of Vaginal Micronized Progesterone for Withdrawal Bleeding in Patients With Polycystic Ovarian Syndrome

Fundacion Dexeus

Phase NA Completed
15 enrolled

Anovulation, Polycystic Ovary Syndrome, Hyperandrogenism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡